{"title":"Epitaxial heterodimensional structures for efficient tin halide perovskite LEDs","authors":"Qian Teng , Jinyang Li , Fanglong Yuan","doi":"10.1016/j.matt.2024.05.015","DOIUrl":null,"url":null,"abstract":"<div><p>Environmentally friendly tin perovskites show promise as substitutes for their toxic lead counterparts in light-emitting diodes (LEDs), yet their device performance significantly trails behind that of lead perovskites. In a recent study published in <em>Nature Nanotechnology</em>, Wang et al. developed efficient tin-based perovskite LEDs with efficiency of 11.6% based on high-quality, large-sized epitaxial heterodimensional bilayer perovskite structure prepared via a straightforward spin-coating process.</p></div>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":4.0000,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"88","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590238524002406","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Environmentally friendly tin perovskites show promise as substitutes for their toxic lead counterparts in light-emitting diodes (LEDs), yet their device performance significantly trails behind that of lead perovskites. In a recent study published in Nature Nanotechnology, Wang et al. developed efficient tin-based perovskite LEDs with efficiency of 11.6% based on high-quality, large-sized epitaxial heterodimensional bilayer perovskite structure prepared via a straightforward spin-coating process.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.